Celeste M. Boesjes

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.

Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.

Journal: Expert opinion on biological therapy

Published: December 01, 2025

A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany.

A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany.

Journal: Acta dermato-venereologica

Published: November 26, 2025

Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.

Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.

Journal: Lancet (London, England)

Published: September 30, 2025

Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.

Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.

Journal: Allergy

Published: July 29, 2025

Response to Bissonnette et al "Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD)".

Response to Bissonnette et al "Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD)".

Journal: Journal of the American Academy of Dermatology

Published: June 03, 2025

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: May 06, 2025

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Journal: Allergy

Published: April 02, 2025

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results.

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 19, 2024

Single-cell sequencing of human Langerhans cells identifies altered gene expression profiles in patients with atopic dermatitis.

Single-cell sequencing of human Langerhans cells identifies altered gene expression profiles in patients with atopic dermatitis.

Journal: ImmunoHorizons

Published: November 13, 2024

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.

Journal: JAMA dermatology

Published: August 07, 2024

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment.

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: June 21, 2024

Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?

Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 16, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026